iShares Broad USD Investment Grade Corporate Bond (USIG) Stock Price Today
Aura AI Summary
Key Stats
- $17.83BMarket Cap
- 2,141,459Volume
- Fixed IncomeSector
- $52.6952W High
- $48.5452W Low
- 48 DaysTypical Hold Time
- -Enterprise Value
- -Div Yield
- -Trading Activity
Track iShares Broad USD Investment Grade Corporate Bond (USIG) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, iShares Broad USD Investment Grade Corporate Bond has traded between a low of $48.54 and a high of $52.69, highlighting its annual price range. Buy and sell iShares Broad USD Investment Grade Corporate Bond shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About iShares Broad USD Investment Grade Corporate Bond
USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.
Most Recent News
Oculis completes patient randomization in trial for precision treatment of TNFR1-mediated dry eye disease
Oculis Holding AG has completed patient randomization in its PREDICT-1 clinical trial testing Licaminlimab, a precision medicine targeting TNFR1-mediated dry eye disease (DED). Two-thirds of the 176 enrolled patients carry a genetic variant linked to...

Ekalia partners with Telix to boost astatine-211 production in the US for cancer therapy.
Ekalia, a joint venture between IBA and Framatome, has signed a collaboration agreement with Telix Pharmaceuticals to accelerate the production of astatine-211 in the United States. Astatine-211 is a promising alpha-emitting radioisotope used in targ...

Roche unveils pivotal cancer drug data at ESMO 2026, highlighting advances in lung and breast cancer treatments.
At ESMO 2026, Roche presented key Phase III trial results showcasing significant advances in cancer treatment. Divarasib demonstrated superior efficacy over first-generation KRAS G12C inhibitors in advanced lung cancer, potentially setting a new stan...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.